首页> 外文会议>GR-I international conference on new Laser technologies and applications >bcl-2 anti-apoptotic oncoprotein suppresses angiogenesis in non-smallcell lung cancer: implications in resistance to photodynamic treatment?,
【24h】

bcl-2 anti-apoptotic oncoprotein suppresses angiogenesis in non-smallcell lung cancer: implications in resistance to photodynamic treatment?,

机译:bcl-2抗凋亡癌蛋白抑制非小细胞肺癌的血管生成:对光动力治疗的抵抗性的意义?,

获取原文

摘要

Abstract: PDT cytotoxicity is likely to occur through photooxidative reactions. In that way mechanisms that define poor oxygenation should be involved in defining resistance to photo-dynamic treatment (PDT). On the other hand bcl-2 anti- apoptotic protein has been shown to delay cell death and protect cells from toxic oxidative products. We examined 134 specimens from T1,2-NO,1 staged patients treated with surgery alone. Specimens were immunohistochemically examined for vascular grade using the JC70 MoAb, and bcl-2 oncoprotein expression. Bcl-2 expression correlated with low vascular grade. Only 3/27 of bcl2$PLU case had high angiogenesis vs. 34/107 of cases without bcl-2 expression. In the present study we provide evidence that bcl-2 overexpression directly suppresses angiogenesis in non-small cell lung cancer, which obviously results in decreased blood supply and oxygenation. This finding implies that reduced intratumoral angiogenesis and immortalizing oncoprotein overexpression are linked to each other and may have a role in defining tumors resistant to PDT. !9
机译:摘要:PDT的细胞毒性很可能通过光氧化反应发生。以此方式,在确定对光动力处理(PDT)的抵抗力时应涉及定义氧合不良的机制。另一方面,bcl-2抗凋亡蛋白已被证明可延迟细胞死亡并保护细胞免受毒性氧化产物的侵害。我们检查了T1,2-NO,1分期仅接受手术治疗的患者的134个标本。使用JC70 MoAb和bcl-2癌蛋白表达,通过免疫组织化学方法对样本进行血管分级检查。 Bcl-2表达与低血管等级相关。 bcl2 $ PLU病例中只有3/27的血管发生高,而无bcl-2表达的病例为34/107。在本研究中,我们提供了bcl-2过表达直接抑制非小细胞肺癌血管生成的证据,这显然导致血液供应和氧合减少。该发现暗示减少的肿瘤内血管生成和永生化的癌蛋白过度表达彼此相关联,并且可能在确定对PDT具有抗性的肿瘤中起作用。 !9

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号